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interchanged and absolute values can be compared directly. 
Best reproducibility is obtained with higher sampling den-
sity even in patients with reduced visual acuity due to dia-
betic macular edema.  Copyright © 2008 S. Karger AG, Basel 
 Introduction 
 Diabetic retinopathy is a leading cause of severe visual 
impairment and blindness in the developed countries. The 
incidence and prevalence are high and continue to increase 
 [1] : it is estimated that currently alone in the USA 10.2 mil-
lion adults aged 40 years or older have diabetes mellitus. 
Besides proliferative disease diabetic macular edema is the 
major vision-threatening retinal change  [2] . For its treat-
ment the Early Treatment Diabetic Retinopathy Study 
(ETDRS) has defined distinct criteria and shown the ef-
fectiveness of focal laser coagulation  [3, 4] . In addition sev-
eral new medical treatment options have become available 
recently, such as anti-VEGF agents or PKC inhibitors  [5, 6] . 
Therefore appropriate and timely detection of macular 
edema has increasing importance in order to offer patients 
the best possible treatment and prevent vision loss.
 Besides stereoscopic, biomicroscopic fundus exami-
nation  [7] , over the last years new objective methods were 
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 Abstract 
 Objective: The purpose of the study was to investigate if ab-
solute values and reproducibility of thickness maps obtained 
from 2 optical coherence tomography (OCT) scanning pro-
tocols, regular high-resolution and fast low-density mode, 
differ in patients with diabetic macular edema.  Methods: A 
total of 26 consecutive patients undergoing fluorescein an-
giography and Stratus OCT scanning for the evaluation of 
diabetic macular edema at the Departments of Ophthalmol-
ogy in Munich and Vienna were included.  Results: Retinal 
thickness of the central field of the thickness map measured 
by fast retinal thickness protocol was 287  8 97 and 290  8 
113   m by the regular protocol. This difference as well as that 
for all other fields was not statistically significant. Three 
times repeated measurements applying both OCT scanning 
modes in 10 patients yielded very good intrasession correla-
tion coefficients between 0.70 and 0.99, with corresponding 
intrasession standard deviations ranging between 6 and 16 
  m. The fast mode yielded slightly less reproducible values 
than the regular mode. Visual acuity did not influence the 
results.  Conclusion: In practice both scanning modes can be 
 Received: March 18, 2007 
 Accepted after revision: July 9, 2007 
 Published online: April 25, 2008 
 Aljoscha S. Neubauer, MD, MBA 
 Department of Ophthalmology, Ludwig Maximilians University Munich 
 Mathildenstrasse 8 ,  DE–80336 Munich (Germany) 
 Tel. +49 89 5160 5160, Fax +49 9131 5160 3051
E-Mail aljoscha.neubauer@med.uni-muenchen.de 
 © 2008 S. Karger AG, Basel
0030–3747/08/0405–0235$24.50/0 
 Accessible online at:
www.karger.com/ore 
 Ceklic /Maár /Neubauer 
 
Ophthalmic Res 2008;40:235–240236
established to quantify the retinal thickness of the poste-
rior pole. Optical coherence tomography (OCT) is most 
frequently applied and allows objective measurements of 
macular thickness. With several scans it can generate de-
tailed retinal thickness maps covering the posterior pole. 
The instrument allows to reliably detect such small in-
creases of retinal thickness of  ! 10   m  [8–10] , while ste-
reoscopic fundus examination usually only detects reti-
nal thickening of approximately 100   m  [11] . OCT there-
fore is believed to be superior to clinical examination for 
detecting small amounts of retinal thickening in diabetic 
macular edema  [12, 13] . However, the currently most fre-
quently applied OCT, the Stratus OCT (Carl Zeiss Med-
itec, Jena, Germany), offers 2 modes for measuring mac-
ular thickness maps: a regular high-resolution mode and 
a fast mode. Although the resolution in the x-y plane and 
scanning times differ significantly, both modes are ap-
plied and interchanged in clinical practice, to date with-
out proper validation. Knowledge about any possible dif-
ferences between the 2 scanning modes is especially of 
importance for cases where only the fast mode gives re-
sults due to patient disability or compliance. Therefore, 
the aim of this study was to investigate if absolute values 
and reproducibility of these 2 OCT scanning modes dif-
fer in patients with diabetic macular edema.
 Methods  
 Patients 
 A total of 26 consecutive patients undergoing fluorescein an-
giography and Stratus OCT scanning for the evaluation of dia-
betic maculopathy at the Departments of Ophthalmology in Mu-
nich and Vienna were included in this study. From each patient 
only 1 eye was randomly selected for further analysis. Inclusion 
criteria were acceptable metabolic control defined by a hemoglo-
bin A 1c of  ! 8%, acceptable control of blood pressure ( ! 140/90 mm 
Hg) and some degree of clinically significant diabetic macular 
edema according to the ETDRS criteria  [14] on clinical stereo-
scopic slit lamp examination. Both proliferative and nonprolif-
erative diabetic retinopathy were included and no previous sur-
gery to the posterior segment was allowed, while mild focal laser 
therapy was. Further exclusion criteria were neovascular glauco-
ma, no visual function (stability of fixation was no inclusion or 
exclusion criteria), vitreous hemorrhage and all other eye diseas-
es, especially those involving the macula. A full ophthalmological 
examination including a dilated (1% tropicamide) stereoscopic 
fundus exam (biomicroscope, 78-dpt lens) was performed by ret-
inal specialists (A.S.N., N.M.). In all patients both fluorescein an-
giography and OCT were carried out after informed consent. All 
research was conducted in accordance with institutional guide-
lines and board approval and conformed to the tenets of the World 
Medical Association Declaration of Helsinki.
 OCT Measurements  
 OCT (Carl Zeiss Meditec) was performed with a commercial-
ly available unit of the Stratus OCT-III. The principles of OCT 
have been described in detail elsewhere  [15, 16] . In this study soft-
ware version 4.04 was applied to measure retinal thickness apply-
ing a scan length of 6.0 mm. Internal fixation of the OCT was 
used. Six radial scans every 30° were performed and the instru-
ment’s built-in, automatic mapping algorithm was applied to au-
tomatically calculate the retinal maps. Retinal thickness in the 9 
ETDRS fields was analyzed. In each patient, 2 maps were gener-
ated: 1 consisting of scans in the regular scanning mode applying 
512 A scans and 1.28 s per scan and 1 with the fast macular scan-
ning applying less dense 128 A scans in 0.32 s per scan. The 2 scan 
protocols were performed in random order. Additionally, in 10 
randomly selected patients the 2 mapping protocols (fast and reg-
ular) were applied 3 times in random order to determine the in-
trasession reproducibility.
 Statistics 
 Data were collected and analyzed using SPSS 13.0 for Win-
dows (SPSS Inc., Chicago, Ill., USA). On all statistical tests p  ! 
0.05 was considered significant. Multi- and univariate analyses 
were applied. Paired testing and nonparametrical methods (e.g. 
Spearman correlation) were chosen where appropriate, which was 
especially the case for the not normally distributed OCT thick-
ness data.
Table 1. Patient characteristics
Distribution Statistical 
significance
p
Gender 18 male (69)
8 female (31)
0.07
Eye 10 right (38)
16 left (62)
0.33
Age, years 64820 [24–77] –
Diabetes type 9 IDDM (35)
17 NIDDM (65)
0.17
Duration of diabetes,
years 14814 [1–26] –
Hemoglobin A1c, % 7.080.6 [5.7–7.7] –
Retinopathy level 2 mild NPDR (8)
13 moderate NPDR (50) 
5 severe NPDR (19)
6 PDR (23)
0.02*
Visual acuity
(logMAR of Snellen) 0.4080.41 [0–2.0] –
Given are the median with interquartile range in square brack-
ets or number of patients with percentages in parentheses. * p = 
0.02: significant difference. IDDM = Insulin-dependent diabetes 
mellitus; NIDDM = non-insulin-dependent diabetes mellitus; 
NPDR = nonproliferative diabetic retinopathy; PDR = prolifera-
tive diabetic retinopathy.
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 Results 
 Patients 
 The demographic characteristics of the 26 patients in-
cluded are summarized in  table 1 . Visual acuity ranged 
from logMAR 0–2 with a median of 0.40, corresponding 
to Snellen 20/50 (range 20/2,000–20/20).
 OCT Macular Map Comparison 
 The median retinal thickness of the central field mea-
sured by the fast retinal thickness protocol was 287  8 97 
and 290  8 113   m (median  8 interquartile range) by the 
regular macular retinal thickness protocol. This differ-
ence as well as that for all other fields was not statistically 
significant. A sample patient illustrating the good concor-
dance of the results is shown in  figure 1 . The details of the 
measurements are listed in  table 2 . The correlation coef-
ficients of the values obtained by the 2 scanning modes 
were very good, ranging between 0.72 and 0.95. 
 OCT Macular Map Reproducibility 
 The 10 patients with repeat measurements had a me-
dian visual acuity of 0.52 logMAR ranging from 0 to 1.3, 
 Fig. 1. Patient with diabetic macular ede-
ma.  a Color fundus photograph of the left 
eye of a patient with mild clinically signif-
icant diabetic macular edema.  b Early 
phase of fluorescein angiography.  c Late 
phase of fluorescein angiography.  d Cor-
responding regular macular thickness 
map computed from high-density scans 
(1.28 s/scan).  e Corresponding fast macu-
lar thickness map computed from low-
density scans (0.32 s/scan). 
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which corresponds to Snellen 20/50 with a range from 
20/400 to 20/20.  Table 3 gives the intrasession correlation 
coefficients (ICC) and the intrasession reproducibility 
for those patients. Very good ICCs between 0.70 and 0.99 
are obtained, the corresponding intrasession standard 
deviations range between 6 and 16   m. The session stan-
dard deviations did not correlate with any other factor 
included in the study, especially not with visual acuity.
 Discussion 
 OCT has become a valuable imaging modality in the 
evaluation and management of various macular diseases, 
particularly with regard to diseases that result in abnor-
mal macular thickness, such as macular edema. The Zeiss 
Stratus OCT allows not only good axial resolution of ap-
proximately 10   m but also faster scanning than previ-
ous time domain models. This may be used for increasing 
the number of A scans as with the ‘regular’ macular map 
mode or allow faster scanning with a lower number of A 
scans as with the ‘fast’ macular thickness mode. Faster 
scanning should theoretically reduce motion artifacts 
and might therefore be beneficial in patients with re-
duced visual acuity. On the other hand due to less lateral 
resolution after the instrument’s software processing the 
resulting thickness measurements may yield higher vari-
ability. The current study showed in patients with dia-
betic macular edema that no large differences exist be-
tween the 2 scanning modes. The variation of the OCT 
macular maps acquired in a longer time but with high 
lateral resolution was consistently lower (see  table 3 ) than 
for the fast mode. Differences were, however, small. As 
absolute measurements did not differ between the 2 map-
Table 2. Comparison of fast and regular OCT maps in diabetic macular edema
OCT field Regular map
m
Fast map
m
Significance 
of median 
difference
Correlation 
of regular and 
fast map values
Significance of 
correlation
p
1 (center field) 2908113 287897 n.s. 0.95 <0.001
2 (central superior) 3158105 324898 n.s. 0.92 <0.001
3 (central temporal) 314897 3138118 n.s. 0.84 <0.001
4 (central inferior) 317897 307881 n.s. 0.95 <0.001
5 (central nasal) 295890 306875 n.s. 0.72 <0.001
6 (peripheral superior) 2848109 2768111 n.s. 0.90 <0.001
7 (peripheral temporal) 271892 2838106 n.s. 0.88 <0.001
8 (peripheral inferior) 272877 276886 n.s. 0.88 <0.001
9 (peripheral nasal) 270866 275869 n.s. 0.85 <0.001
Values are medians 8 interquartile ranges. n.s. = Not significant.
Table 3. Reproducibility of fast and regular OCT maps in diabetic macular edema
OCT field Fast maps 
ICC
Fast maps 
intrasession SD, m
Regular maps
ICC
Regular maps
intrasession SD, m
1 (center field) 0.97 10.71 0.99 7.23
2 (central superior) 0.93 10.63 0.95 9.43
3 (central temporal) 0.94 11.12 0.98 8.83
4 (central inferior) 0.93 8.32 0.90 13.23
5 (central nasal) 0.71 14.47 0.85 13.90
6 (peripheral superior) 0.70 13.85 0.88 8.49
7 (peripheral temporal) 0.84 15.93 0.97 9.97
8 (peripheral inferior) 0.95 6.47 0.91 8.44
9 (peripheral nasal) 0.71 16.13 0.96 5.69
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ping modes, this means that in practice both scanning 
modes can be interchanged. Still, the best reproducibility 
is obtained with higher sampling density even in patients 
with reduced visual acuity such as in diabetic macular 
edema.
 These results are in concordance with a paper investi-
gating reproducibility in normal subjects  [17] , where also 
good reproducibilites were found for both scanning 
modes with some advantage for the high-density scans. 
It is remarkable that the same is true for the patients with 
diabetic macular edema investigated in our study, al-
though they have reduced visual acuity and ability to fix-
ate. It appears important that in those patients the 2 scan-
ning modes were applied in random order to avoid any 
bias, e.g. by getting tired. When comparing in detail the 
values reported for the normal subjects in Paunescu et al. 
 [17] , the diabetic patients in our study show between 2 
and 3 times higher session standard deviations for the 
same 3 times repeated measurements. This is believed to 
be related to a reduced ability to fixate due to diabetic 
macular edema. Another possible explanation is that 
scan quality may be impaired by less fixation causing 
higher variance of scan analysis  [18] . Interestingly, no 
correlation between OCT session variability and the pa-
tients’ visual acuity could be shown in our study – fixa-
tion itself was not measured in this study. When transfer-
ring our results it should also be considered that the reti-
nopathy level distribution in patients mostly represented 
more advanced retinopathy levels, while for instance in 
screening settings lower levels are to be expected. In com-
parison to the previous OCT 2000 version, where a repro-
ducibility for macular thickness measurements of  ! 20 
  m was found in diabetic retinopathy  [19] , our current 
study observed a better reproducibility with the Stratus 
OCT. This may be related to the increased sampling den-
sity and axial resolution – and only to some minor degree 
to the higher speed of image acquisition with the Stratus 
OCT.
In summary, in patients with diabetic macular edema, 
fixation loss appears to be less of a concern, as image res-
olution is compromised in a fast macular scan protocol 
as compared to the regular, slower protocol. This regular 
scan protocol provides more data points and may there-
fore be more indicative of changes in the macula  [20] . On 
the other hand differences in map repeatability are small 
and the absolute thickness values do not differ. Therefore 
the values of both protocols can be directly compared. 
This implies that in cases where regular scanning is dif-
ficult one can use the fast macular map, which yields sim-
ilarly reliable results as the slower high-density mode. In 
summary, with the current study in a first attempt the 
comparability of slow and fast scanning has been shown 
in diabetic retinopathy. The results should be confirmed 
in a larger number of patients with time domain OCT 
and with other imaging technology applied in macular 
edema, such as spectral domain OCT.
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